Literature DB >> 9365130

Recovery from diclofenac-induced hypersensitive fulminant hepatitis and prostaglandins.

M Ohana, K Hajiro, H Takakuwa, K Okazaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9365130     DOI： 10.1023/a:1018802014177

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  6 in total

Review 1.  Drug disposition and drug hypersensitivity.

Authors:  B K Park; J W Coleman; N R Kitteringham
Journal:  Biochem Pharmacol       Date:  1987-03-01       Impact factor: 5.858

Review 2.  Diclofenac induced hepatitis. 3 cases with features of autoimmune chronic active hepatitis.

Authors:  L J Scully; D Clarke; R J Barr
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

3.  Toxic effects of intravenous and oral prostaglandin E therapy in patients with liver disease.

Authors:  M S Cattral; I Altraif; P D Greig; L Blendis; G A Levy
Journal:  Am J Med       Date:  1994-10       Impact factor: 4.965

Review 4.  The spectrum of hepatotoxicity due to drugs.

Authors:  S Sherlock
Journal:  Lancet       Date:  1986-08-23       Impact factor: 79.321

5.  Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E. A preliminary report.

Authors:  S B Sinclair; P D Greig; L M Blendis; M Abecassis; E A Roberts; M J Phillips; R Cameron; G A Levy
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

Review 6.  Liver cytoprotection by prostaglandins.

Authors:  J Quiroga; J Prieto
Journal:  Pharmacol Ther       Date:  1993       Impact factor: 12.310
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.